Profile for Australia Patent: 2013226076
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2013226076
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,272,046 | Feb 27, 2033 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 11,147,770 | Feb 27, 2033 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 11,752,106 | Feb 27, 2033 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 12,214,083 | Feb 27, 2033 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 8,883,206 | Feb 27, 2033 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 10,272,046 | Aug 27, 2033 | Vertex Pharms Inc | KALYDECO | ivacaftor |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
